Shenzhen Tianyuan Pharmaceutical Technology Co., Ltd
Lab/Research institutions

地址:B302,2 unit, Jin Lian Building, No. 134 Qianjin 2 Road, Taoyuan village, Xixiang Street, Baoan,Shenzhen,China China (Mainland) SHENZHEN//HONGKONG GUANGDONG//HONGKONG

主营产品:alectinib,Afatinib,Olaparib,Crizotinib,Ibrutinib,Sorafenib tosylate,Osimertinib mesylate,Brigatinib,lenvatinib Mesylate

主要市场:North America South America Eastern Europe Southeast Asia Africa Oceania Mid

业务范围:alectinib,Afatinib,Olaparib,Crizotinib,Ibrutinib,Sorafenib tosylate,Osimertinib mesylate,Brigatinib,lenvatinib Mesylate

注册资本: 300000

公司规模:51 - 100People

成立年份:2018

法人代表:wangchunliang

Amy

86-755-2328419013798224190

sales@tianpharm.com

www.tianpharm.com

Tianyuan pharmaceutical company in Zhangjiang Eastern has built 500 square meters of pilot laboratories, equipped with two sets of 50L glass reactor, four sets of 100L double reactor, six sets of 50L rotary evaporator and matching heating and cooling equipment, to complete the 10kg Pilot complex experiments in complex compounds in Jiaozhou, Qingdao, a steady cooperation of the amplification plant, from 100kg to the tonnage of the enlarged production.

specifical product alectinib,Afatinib,Olaparib,Crizotinib,Ibrutinib,Sorafenib tosylate,Osimertinib mesylate,Brigatinib,lenvatinib Mesylate